Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development

被引：46

作者：

Burns, HD ^{[1
]}

Hamill, TG ^{[1
]}

Eng, W ^{[1
]}

Francis, B ^{[1
]}

Fioravanti, C ^{[1
]}

Gibson, RE ^{[1
]}

机构：

[1] Merck Res Labs, Dept Pharmacol, West Point, PA 19438 USA

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 1999年 / 3卷 / 04期

关键词：

D O I：

10.1016/S1367-5931(99)80059-3

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Improved communication and cooperation between research-driven drug companies and academic positron emmision tomography (PET) centers, coupled with improvements in PET camera resolution, the availability of small animal PET cameras and a growing list of neuroreceptor-specific PET tracers, have all-contributed to a substantial increase in the use and value of PET as a tool in central nervous system drug discovery and development.

引用

页码：388 / 394

页数：7

共 32 条

[1] Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain [J].

Andrée, B ;

Nyberg, S ;

Ito, H ;

Ginovart, N ;

Brunner, F ;

Jaquet, F ;

Halldin, C ;

Farde, L .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (04) :317-323

[2] The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine [J].

Attar-Lévy, D ;

Martinot, JL ;

Blin, J ;

Dao-Castellana, MH ;

Crouzel, C ;

Mazoyer, B ;

Poirier, MF ;

Bourdel, MC ;

Aymard, N ;

Syrota, A ;

Féline, A .

BIOLOGICAL PSYCHIATRY, 1999, 45 (02) :180-186

[3]

BURNS HD, 1996, NUCL MED PRINCIPLES, V2, P1273

[4]

BURNS HD, 1993, NUCL IMAGING DRUG DI

[5]

CAMPBELL B, 1997, DRUG INF J, V31, P989

[6]

CAMPBELL DB, 1997, J NUCL MED, V41, P163

[7] Brain imaging in small animals using microPET [J].

Cherry, SR ;

Chatziioannou, A ;

Shao, YP ;

Silverman, RW ;

Meadors, K ;

Phelps, ME .

QUANTITATIVE FUNCTIONAL BRAIN IMAGING WITH POSITRON EMISSION TOMOGRAPHY, 1998, :3-9

[8]

Christian BT, 1998, INT J MOL MED, V1, P243

[9]

COMAR D, 1995, PET DRUG DEV EVALUAT

[10]

ECKELMAN W, 1999, IN PRESS J CLIN PHAR

← 1 2 3 4 →